INM icon

InMed Pharmaceuticals
INM

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $234K invested in InMed Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

73% less capital invested

Capital invested by funds: $877K → $234K (-$642K)

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$36K
2
+$14.5K
3
+$101

Top Sellers

1
-$101K
2
-$91K
3
-$45K
4
UBS Group
UBS Group
Switzerland
-$9.91K
5
TRCT
Tower Research Capital (TRC)
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$196K
2
$36K
3
$1.68K
4
$252
5
$101
6
$42
7
$38
8
$14
9
$12
10
$10
11
$2
12
$2
13
–
14
–
15
–
16
–